(Q42485649)

1 November 2017

title

A subset of breast cancer predisposes to brain metastasis (English)

1 reference

1 November 2017

Mu-min Shao

1

1 reference

1 November 2017

Jun Liu

2

1 reference

1 November 2017

Joaquim S Vong

3

1 reference

1 November 2017

Yun Niu

4

1 reference

1 November 2017

Barbara Germin

5

1 reference

1 November 2017

Ping Tang

6

1 reference

1 November 2017

Anthony W H Chan

7

1 reference

1 November 2017

Philip C W Lui

8

1 reference

1 November 2017

Bonita K B Law

9

1 reference

1 November 2017

Puay-Hoon Tan

10

1 reference

1 November 2017

Gary M Tse

11

1 reference

1 November 2017

publication date

1 March 2011

1 reference

Medical Molecular Morphology

1 November 2017

published in

1 reference

1 November 2017

volume

44

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

15-20

1 reference

https://scigraph.springernature.com/pub.10.1007/s00795-010-0495-2

1 November 2017

exact match

0 references

cites work

Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment

1 reference

12 December 2020

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).

1 reference

12 December 2020

Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy

1 reference

12 December 2020

The natural history of breast cancer patients with brain metastases

1 reference

12 December 2020

Central nervous system metastasis from breast carcinoma. Autopsy study.

1 reference

12 December 2020

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

1 reference

12 December 2020

Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

1 reference

12 December 2020

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

1 reference

12 December 2020

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

1 reference

12 December 2020

Brain metastases from breast cancer: identification of a high-risk group

1 reference

12 December 2020

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.

1 reference

12 December 2020

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

1 reference

12 December 2020

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study

1 reference

12 December 2020

Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer

1 reference

12 December 2020

Brain metastases: the HER2 paradigm

1 reference

12 December 2020

Estrogen and progesterone receptor content of primary and secondary breast carcinoma: influence of time and treatment

1 reference

12 December 2020

Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer

1 reference

12 December 2020

High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel

1 reference

12 December 2020

Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival

1 reference

12 December 2020

c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues

1 reference

12 December 2020

Estrogen receptor: A prognostic factor in breast cancer

1 reference

12 December 2020

Central nervous system metastases in women after multimodality therapy for high risk breast cancer

1 reference

12 December 2020

Radiation therapy for brain metastases

1 reference

12 December 2020

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

12 December 2020

Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer

1 reference

12 December 2020

Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer

1 reference

12 December 2020

HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy

1 reference

12 December 2020

Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer.

1 reference

12 December 2020

Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer

1 reference

12 December 2020

Impact of metastatic estrogen receptor and progesterone receptor status on survival

1 reference

12 December 2020

Brain metastases in breast cancer: prognostic factors and management

1 reference

12 December 2020

Breast carcinoma: Pattern of metastasis at autopsy

1 reference

12 December 2020

Immunohistochemical profiles of brain metastases from breast cancer

1 reference

12 December 2020

Central nervous system metastases in patients with high-risk breast carcinoma after multimodality treatment

1 reference

12 December 2020

Central nervous system metastasis in breast cancer

1 reference

12 December 2020

Patterns of disease spread in metastatic breast carcinoma: influence of estrogen and progesterone receptor status

1 reference

12 December 2020

Breast cancer metastasis to the central nervous system

1 reference

12 December 2020

Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status

1 reference

12 December 2020

Central nervous system metastases in breast cancer patients administered trastuzumab

1 reference

12 December 2020

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

1 reference

12 December 2020

Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases

1 reference

12 December 2020

CNS metastases in breast cancer

1 reference

12 December 2020

Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer.

1 reference

12 December 2020

HER-2/neu Status in Breast Cancer Metastases to the Central Nervous System

1 reference

12 December 2020

The influence of basal phenotype on the metastatic pattern of breast cancer.

1 reference

12 December 2020

Management of central nervous system metastases

1 reference

12 December 2020

Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer

1 reference

12 December 2020

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel

1 reference

12 December 2020

Central nervous system metastases in HER-2-overexpressing metastatic breast cancer: a treatment challenge

1 reference

12 December 2020

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

12 December 2020

Expression of epidermal growth factor receptors associated with lack of response to endocrine therapy in recurrent breast cancer

1 reference

12 December 2020

10.1007/S00795-010-0495-2

Identifiers

DOI

1 reference

1 November 2017

1 reference